Refractory henoch–schÖnlein purpura: atypical aetiology and management

ConclusionRituximab might be efficacious in treatment of hspn, more studies are needed to assess long‐term safetey and efficacy.
Source: Journal of Renal Care - Category: Urology & Nephrology Authors: Tags: Case Report Source Type: research